mirdametinib 1 MG Tablet for Oral Suspension

RxCUI: 2705632
RxNorm name: mirdametinib 1 MG Tablet for Oral Suspension
Display name: mirdametinib 1 MG Tablet for Oral Suspension
Full name: mirdametinib 1 MG Tablet for Oral Suspension
Term type: SCD
Status: DailyMed mapping
Updated: 2026-06-04 23:38:57

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Gomekli	MIRDAMETINIB	SpringWorks Therapeutics, Inc.	4c41bf90-5fa7-4935-a95c-e047ea6bbf8e	2026-07-10	Warnings, Adverse reactions	Exact identifier rxcui: 2705632

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
4c41bf90-5fa7-4935-a95c-e047ea6bbf8e	mirdametinib 1 MG Tablet for Oral Suspension	SCD	6	These highlights do not include all the information needed to use GOMEKLI safely and effectively. See full prescribing information for GOMEKLI. GOMEKLI TM (mirdametinib) capsules, for oral use GOMEKLI TM (mirdametinib) tablets for oral suspension Initial U.S. Approval: 2025	20260511
4c41bf90-5fa7-4935-a95c-e047ea6bbf8e	mirdametinib 1 MG Tablet for Oral Suspension	PSN	6	These highlights do not include all the information needed to use GOMEKLI safely and effectively. See full prescribing information for GOMEKLI. GOMEKLI TM (mirdametinib) capsules, for oral use GOMEKLI TM (mirdametinib) tablets for oral suspension Initial U.S. Approval: 2025	20260511